NYT Reports KG To Acquire Abuse-Resistant Drug
Tweet
Share
E-mailGet Alerts KG Hot Sheet
Join SI Premium – FREE
The New York Times reported King Pharmaceuticals (NYSE: KG) plans to obtain the rights to an abuse-resistant version of painkiller OxyContin from biotech company Pain Therapeutics. The announcement is expected sometime today.
You May Also Be Interested In
- OpenAI eyes 2027 hardware entry with high-end smart speaker, Bloomberg reports
- JPMorgan upgrades Kraft Heinz credit to Overweight on deleveraging outlook
- BTIG sees momentum stocks rally nearing historical rebound levels
Create E-mail Alert Related Categories
ContributorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
